Free Trial
→ Elon Musk’s 4th Wealth Window Set to Open by October 30 (From Brownstone Research) (Ad)tc pixel Free BACK Stock Alerts

IMAC (BACK) Competitors

IMAC logo
$0.0001 0.00 (-83.33%)
As of 10:21 AM Eastern
Compare

BACK vs. AONCW, BTSGU, LFMDP, NIVFW, and PIIIW

Should you buy IMAC stock or one of its competitors? IMAC's main competitors and comparable companies include American Oncology Network (AONCW), BrightSpring Health Services (BTSGU), LifeMD (LFMDP), NewGenIvf Group (NIVFW), and P3 Health Partners (PIIIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does IMAC compare to American Oncology Network?

American Oncology Network (NASDAQ:AONCW) and IMAC (NASDAQ:BACK) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

5.8% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
IMAC N/A N/A -325.44%

In the previous week, American Oncology Network's average media sentiment score of 0.00 equaled IMAC'saverage media sentiment score.

Company Overall Sentiment
American Oncology Network Neutral
IMAC Neutral

American Oncology Network has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
IMAC$72.05K0.01-$9.42M-$3.12N/A

Summary

American Oncology Network and IMAC tied by winning 2 of the 4 factors compared between the two stocks.

How does IMAC compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSGU) and IMAC (NASDAQ:BACK) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

5.8% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
IMAC
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
IMAC N/A N/A -325.44%

In the previous week, BrightSpring Health Services' average media sentiment score of 1.60 beat IMAC's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Overall Sentiment
BrightSpring Health Services Very Positive
IMAC Neutral

BrightSpring Health Services has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37BN/AN/AN/AN/A
IMAC$72.05K0.01-$9.42M-$3.12N/A

Summary

BrightSpring Health Services beats IMAC on 4 of the 6 factors compared between the two stocks.

How does IMAC compare to LifeMD?

IMAC (NASDAQ:BACK) and LifeMD (NASDAQ:LFMDP) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

In the previous week, LifeMD had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for IMAC. LifeMD's average media sentiment score of 0.94 beat IMAC's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
IMAC Neutral
LifeMD Positive

5.8% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

LifeMD has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.01-$9.42M-$3.12N/A
LifeMD$191.59MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
LifeMD N/A N/A N/A

Summary

LifeMD beats IMAC on 4 of the 6 factors compared between the two stocks.

How does IMAC compare to NewGenIvf Group?

IMAC (NASDAQ:BACK) and NewGenIvf Group (NASDAQ:NIVFW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

5.8% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

NewGenIvf Group has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.01-$9.42M-$3.12N/A
NewGenIvf Group$4.63MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
NewGenIvf Group N/A N/A N/A

In the previous week, NewGenIvf Group had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for NewGenIvf Group and 0 mentions for IMAC. NewGenIvf Group's average media sentiment score of 0.89 beat IMAC's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company Overall Sentiment
IMAC Neutral
NewGenIvf Group Positive

Summary

NewGenIvf Group beats IMAC on 4 of the 6 factors compared between the two stocks.

How does IMAC compare to P3 Health Partners?

IMAC (NASDAQ:BACK) and P3 Health Partners (NASDAQ:PIIIW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
P3 Health Partners N/A N/A N/A

5.8% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, P3 Health Partners' average media sentiment score of 1.41 beat IMAC's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company Overall Sentiment
IMAC Neutral
P3 Health Partners Positive

P3 Health Partners has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.01-$9.42M-$3.12N/A
P3 Health Partners$1.50BN/AN/AN/AN/A

Summary

P3 Health Partners beats IMAC on 3 of the 5 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BACK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BACK vs. The Competition

Export
MetricIMACHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$10.51B$7.44B$12.94B
Dividend YieldN/A2.58%2.50%27.63%
P/E Ratio0.0027.65177.3117.70
Price / Sales0.014.78567.9576.22
Price / CashN/A116.0376.5451.88
Price / Book0.005.0710.295.85
Net Income-$9.42M$315.68M$3.50B$380.67M
7 Day PerformanceN/A-1.26%-5.37%-4.97%
1 Month PerformanceN/A-5.60%-8.55%-6.95%
1 Year PerformanceN/A9.92%0.43%-5.99%

IMAC Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BACK
IMAC
N/A$0.00
-83.3%		N/A-99.1%$0.00$72.05KN/A180
AONCW
American Oncology Network
N/A$0.00
flat		N/AN/A$0.00$1.34BN/A1,525
BTSGU
BrightSpring Health Services
N/A$210.07
-0.4%		N/A+95.4%$0.00$14.37BN/A23,500
LFMDP
LifeMD
N/A$22.44
+0.4%		N/A-6.6%$0.00$191.59MN/A384
NIVFW
NewGenIvf Group
N/A$0.01
-2.4%		N/A-29.4%$0.00$4.63MN/A87

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BACK) was last updated on 10/16/2026 by MarketBeat.com Staff.
From Our Partners
Undiscovered Sub-$1 Gold-Silver Royalty Stock Takes Flight
A small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...
Digest Publishing | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
The oil check Munger called his best deal
Charlie Munger's $1,000 oil investment in 1962 later paid about $70,000 a year, totaling roughly $1 million ov...
The Oxford Club | Sponsoredtc pixel
A simple options strategy that changed one trader's path
Ian Cooper went from a financially stressed, struggling journalist to a trader who discovered a repeatable opt...
TradeWins | Sponsoredtc pixel
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehm...
Weiss Ratings | Sponsoredtc pixel